|
|
||||||||
University of California School of Medicine and San Francisco General Hospital, San Francisco, California
Correspondence: For reprints contact: Mathews B. Fish, Associate Director, Clinical Laboratories, Building 100, Room 163, San Francisco General Hospital, 1001 Potrero and 22nd Sts., San Francisco, Calif. 94110.
ABSTRACT
This report describes a procedure that involves the absolute and simultaneous measure meat of free 58Co-labeled B12 (58Co-B12) and IF-bound 57Co-B12 [57Co-B12(IF)] using a non-absorbable marker (60Co microspheres) and incomplete stool collections. Absorption by this procedure in controls and megaloblastic folate deficient patients averaged 55% for B12 and 66% for B12(IF) whereas absorption in megaloblastic patients with pernicious anemia averaged 7% of B12 and 34% of B12(IF). These stool absorption data compared closely with simultaneous whole-body counter measurements. In addition, measurement and evaluation were made of a 58Co-B12(IF):57Co-B12 ratio in a single plasma sample obtained 68 hr after test dose administration. This ratio was 1.1 in controls and folate deficiency, and 7.8 in patients with pernicious anemia. These plasma measurements are rapidly obtained and may furnish diagnostic information regarding possible intrinsic factor deficiency when quantitative results are equivocal or specimen collection is inadequate.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |